A Pediatric Patient with Intravenous Cyclosporine Anaphylaxis Who Tolerated the Oral Form

References (8)

1. Bickel M, Tsuda H, Amstad P, Evequoz V, Mergenhagen SE, Wahl SM, Pluznik DH. Differential regulation of colony-stimulating factors and interleukin 2 production by cyclosporin A. Proc Natl Acad Sci U S A 1987;84:3274- 3277
2. Ringden O. Cyclosporine in allogeneic bone marrow transplantation. Transplantation 1986;42:445-452
3. Beauchesne PR, Chung NS, Wasan KM. Cyclosporine A: a review of current oral and intravenous delivery systems. Drug Dev Ind Pharm 2007;33:211-220
4. Kuiper RA, Malingré MM, Beijnen JH, Schellens JH. Cyclosporine-induced anaphylaxis. Ann Pharmacother 2000;34:858-861
5. Volcheck GW, Van Dellen RG. Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review. Ann Allergy Asthma Immunol 1998;80:159- 163
6. Gelderblom H, Verweij J, Nooter K, Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 2001;37:1590- 1598
7. Takamatsu Y, Ishizu M, Ichinose I, Ogata K, Onoue M, Kumagawa M, Suzumiya J, Tamura K. Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient. Bone Marrow Transplant 2001;28:421-423
8. Nicolai S, Bunyavanich S. Hypersensitivity reaction to intravenous but not oral tacrolimus. Transplantation 2012;94:61-63.